Magnolia Capital Advisors’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,470
| Closed | -$27.7K | – | 160 |
|
|
2024
Q1 | $27.7K | Sell |
2,470
-207
| -8% | -$2.32K | 0.02% | 91 |
|
|
2023
Q4 | $65.4K | Sell |
2,677
-209
| -7% | -$5.11K | 0.05% | 90 |
|
|
2023
Q3 | $32.8K | Buy |
+2,886
| New | +$32.8K | 0.03% | 64 |
|
|
2023
Q2 | – | Sell |
-2,990
| Closed | -$283K | – | 151 |
|
|
2023
Q1 | $283K | Buy |
2,990
+158
| +6% | +$14.9K | 0.15% | 121 |
|
|
2022
Q4 | $276K | Buy |
2,832
+42
| +2% | +$4.09K | 0.18% | 114 |
|
|
2022
Q3 | $720K | Buy |
2,790
+559
| +25% | +$144K | 0.61% | 54 |
|
|
2022
Q2 | $414K | Buy |
2,231
+995
| +81% | +$185K | 0.38% | 83 |
|
|
2022
Q1 | $121K | Buy |
1,236
+420
| +51% | +$41.1K | 0.05% | 189 |
|
|
2021
Q4 | $133K | Buy |
816
+128
| +19% | +$20.9K | 0.04% | 195 |
|
|
2021
Q3 | $188K | Buy |
688
+35
| +5% | +$9.56K | 0.07% | 176 |
|
|
2021
Q2 | $258K | Buy |
+653
| New | +$258K | 0.11% | 119 |
|
|
2021
Q1 | – | Sell |
-585
| Closed | -$221K | – | 125 |
|
|
2020
Q4 | $221K | Buy |
585
+49
| +9% | +$18.5K | 0.14% | 105 |
|
|
2020
Q3 | $202K | Sell |
536
-68
| -11% | -$25.6K | 0.16% | 97 |
|
|
2020
Q2 | $297K | Sell |
604
-7
| -1% | -$3.44K | 0.38% | 56 |
|
|
2020
Q1 | $225K | Sell |
611
-57
| -9% | -$21K | 0.44% | 64 |
|
|
2019
Q4 | $472K | Buy |
+668
| New | +$472K | 0.45% | 38 |
|